Page last updated: 2024-12-07

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

You're describing a **synthetic lipid** with a very specific structure. Let's break down its components and understand its significance in research:

**Structure:**

* **1-hexadecyl:** This part indicates a 16-carbon chain (hexadecane) attached to the first carbon of the glycerol backbone.
* **3-trifluoroethyl:** A trifluoroethyl group (CF3CH2-) is attached to the third carbon of glycerol.
* **glycero-sn-2-phosphomethanol:** This refers to the core structure: glycerol (a three-carbon sugar alcohol) with a phosphate group (PO4) linked to the second carbon (sn-2) and a methanol (CH3OH) group attached to the phosphate.

**Overall:** This synthetic lipid is basically a modified phospholipid with a long hydrocarbon tail, a trifluoroethyl group, and a phosphomethanol head.

**Importance in Research:**

This specific lipid, or variations of it, is likely used in research for several reasons:

* **Cell membrane studies:**
* The long hydrocarbon tail mimics the hydrophobic nature of fatty acid chains found in natural phospholipids, which make up cell membranes.
* The trifluoroethyl group could be used to introduce specific properties or functionalities to the membrane, such as increased fluorogenicity for imaging or altered interactions with other molecules.
* **Drug delivery:**
* The presence of the phosphomethanol head makes this lipid potentially useful for drug delivery applications. The phosphate group can interact with charged drug molecules, while the hydrophobic tail can help embed the drug within a lipid-based delivery system (like liposomes).
* **Material science:**
* Such synthetic lipids can be used to create novel materials with unique properties. For example, they can be incorporated into lipid bilayers or self-assembled structures for applications in biocompatible coatings, sensors, or even drug delivery systems.

**Crucial Information:**

To understand its specific importance in research, you need more context. For example:

* **Where did you encounter this lipid?** A research paper, a chemical database, or a specific lab protocol?
* **What is the research field?** Cell biology, drug development, materials science?
* **What are the specific properties being studied?** Fluidity, permeability, drug encapsulation, etc.?

By providing more details about the context of this lipid, we can better understand its significance in the specific research area.

Cross-References

ID SourceID
PubMed CID132064
MeSH IDM0210609

Synonyms (8)

Synonym
mj-33
hexadecanoic acid, 2-((hydroxymethoxyphosphinyl)oxy)-3-(2,2,2-trifluoroethoxy)propyl ester, (+-)-
1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol
137464-44-9
[2-[hydroxy(methoxy)phosphoryl]oxy-3-(2,2,2-trifluoroethoxy)propyl] hexadecanoate
aztcomapqrbirm-uhfffaoysa-n
DTXSID80929801
2-{[hydroxy(methoxy)phosphoryl]oxy}-3-(2,2,2-trifluoroethoxy)propyl hexadecanoatato(2-)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (34.78)18.2507
2000's5 (21.74)29.6817
2010's9 (39.13)24.3611
2020's1 (4.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.49 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]